News & Announcements

Member Spotlight: Dr. José Romero

José R. Romero, MD, is the Arkansas Secretary of Health and Director of the Department of Health (ADH). He is a Professor of Pediatrics in the Department of Pediatrics at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, Arkansas. He has board certification in Pediatrics and Pediatric Infectious Diseases. Dr. Romero earned…

Aug. 6, 2021

President’s Letter from Dr. Kris Bryant

Drum roll, please. The PIDS/IDSA Clinical Practice Guidelines on the Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics were published in JPIDS this week. I want to acknowledge all the members of the writing team, led by Dr. Charles Woods, and our partners at IDSA. Advancing clinical care in infectious diseases (and supporting our…

Call for Applications for Editor-in-Chief, Journal of the Pediatric Infectious Diseases Society (JPIDS), The Official Journal of PIDS

Please consider this rewarding opportunity! The PIDS Editor Selection Subcommittee of the Publications Committee seeks applications for the next Editor-in-Chief of the Journal of the Pediatric Infectious Diseases Society.  Dr. Theo Zaoutis has led the journal since its inception and will be stepping down in the near future to pursue other opportunities.  JPIDS launched in…

What’s in the News: PIDS Supports Universal Masking for Students and School Staff, COVID-19 Vaccine Mandates for Health Care Workers

PIDS recently announced its strong support of universal masking for all school staff and students 2 years of age and older, as well as vaccination against COVID-19 for all eligible, in line with recommendations from the American Academy of Pediatrics for the beginning of the 2021-2022 school year. The Society’s statement was issued July 28. PIDS also recently joined more than…

What’s in the News: AAP Issues New Guideline for Fever in Infants Younger Than 2 Months

A new clinical practice guideline issued by the American Academy of Pediatrics addresses questions related to evaluating otherwise well-appearing infants between 8-60 days old who develop a fever. The guideline breaks down recommendations for evaluation and care, and ranks the quality of available evidence. Risks and benefits also are detailed, including those concerning invasive procedures…

Member Spotlight: Dr. David Hyun

David Hyun, MD, is the director of the Antibiotic Resistance Project at The Pew Charitable Trusts, a non-profit, non-partisan policy research organization. The Antibiotic Resistance Project conducts research and advocacy that support policies that remove regulatory obstacles and create economic incentives for the innovation of new antibiotics and ensure antibiotic stewardship in healthcare and animal…

Research Funding Opportunity for Fellows and Junior Faculty Announced in July Extended

PIDS has extended the deadline for the research funding opportunity for fellows and junior faculty who identify as underrepresented in medicine (UIM) to October 8, 2021.   Additional details on this opportunity are available at the PIDS Foundation website: https://pidsfoundation.org/awards/academic-pediatric-initiative-on-diversity/. As previously announced, we have partnered with the American Pediatric Association for the 2022 Research in Academic…

Jul. 9, 2021

President’s Letter from Dr. Kris Bryant

This was a week for celebration. Across the United States, new pediatric infectious diseases fellows began their training. Please join me in extending a warm welcome to the newest members of our PID community. While I hope all have joined the Pediatric Infectious Diseases Society and are receiving this newsletter, I realize that might not…

Updated for COVID-19, Vaccine Handbook App Now Available for Android and iOS Devices

Fully updated for COVID-19 and accessible on Android devices for the first time, the latest version of the Vaccine Handbook App, a comprehensive, practical resource for information about vaccination and vaccine-preventable diseases, is now available. The app provides free, easy access to the full content of the upcoming 10th edition of The Vaccine Handbook: A…

Dengue Vaccine Recommended for Use in U.S. Children in High-risk Areas

At its recent meeting, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted unanimously to recommend use of a three-dose dengue vaccine for children 9 to 16 years old who live in endemic areas, such as Puerto Rico. Made by Sanofi Pasteur, the vaccine, Dengvaxia, protects against disease caused by all…

PIDS On Call Webinar

Update on Myocarditis Following COVID-19 Immunization PIDS On Call is a new initiative of PIDS that uses a webinar-based format to bring important clinical issues within pediatric infectious diseases to PIDS members. In this month’s PIDS On Call, Drs. Judy Guzman-Cottrill and Buddy Creech discussed what is known, and yet unknown, about myopericarditis in children following receipt of…

What’s in the News: Dengue Vaccine Candidate Demonstrates 62.0% Efficacy

A dengue vaccine candidate had 62.0% efficacy against the illness and 83.6% efficacy against hospitalized dengue in children and adolescents, according to recently reported trial results. The data comes from an ongoing phase 3 study of Takeda Pharmaceutical’s TAK-003 candidate vaccine, which showed continued protection against dengue illness and hospitalization, regardless of previous dengue exposure,…

Improving the health of children worldwide through philanthropic support of scientific and educational programs.

This site uses cookies to provide a better experience for you
Ok